REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 21st, 2023 • Marizyme, Inc. • Surgical & medical instruments & apparatus
This Registration Rights Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is made and entered into as of November 20, 2023 among Marizyme, Inc., a Nevada corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
ContractWarrant Agreement • November 21st, 2023 • Marizyme, Inc. • Surgical & medical instruments & apparatus
THIS WARRANT HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
ContractWarrant Agreement • November 21st, 2023 • Marizyme, Inc. • Surgical & medical instruments & apparatus
THIS WARRANT HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.
CANCELLATION AND EXCHANGE AGREEMENTCancellation and Exchange Agreement • November 21st, 2023 • Marizyme, Inc. • Surgical & medical instruments & apparatus
THIS CANCELLATION AND EXCHANGE AGREEMENT (this “Agreement”), is made and entered into as of November 20, 2023 (the “Effective Date”), between Marizyme, Inc., a Nevada corporation (the “Company”) and _______, an entity/individual (the “Creditor” and together with the Company, the “Parties”).
UNIT PURCHASE AGREEMENTUnit Purchase Agreement • November 21st, 2023 • Marizyme, Inc. • Surgical & medical instruments & apparatus • Nevada
This Unit Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this “Agreement”) is entered into as of November 20, 2023, by and among Marizyme, Inc., a Nevada corporation (the “Company”), and each investor identified on Appendix A hereto (each, including its successors and assigns, an “Investor” and collectively, the “Investors”).
WAIVER AND CONSENTWaiver and Consent • November 21st, 2023 • Marizyme, Inc. • Surgical & medical instruments & apparatus
This WAIVER AND CONSENT (this “Waiver and Consent”) is made and entered into as of _________, 2023 by and between Marizyme, Inc., a Nevada corporation (the “Company”) and Univest Securities, LLC, an entity (the “Placement Agent”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in that certain Placement Agency Agreement dated as of April 27, 2023, by and between the Company and the Placement Agent (the “Placement Agency Agreement”), unless defined otherwise herein.
WAIVER AND CONSENTWaiver and Consent • November 21st, 2023 • Marizyme, Inc. • Surgical & medical instruments & apparatus
This WAIVER AND CONSENT (this “Waiver and Consent”) is made and entered into as of November 20, 2023 by and between Marizyme, Inc., a Nevada corporation (the “Company”) and __________, an entity/individual (the “Investor”).
